The PAFAH1B1 gene helps guide developing brain cells to the right place as the brain forms before birth. This gene plays an important role in building the brain’s usual layers and shape. If you carry a harmful variant in this gene, or if one copy is missing, the brain may develop with a smoother surface than usual. That can lead to seizures, low muscle tone, feeding problems, and developmental delay. Larger missing pieces of chromosome 17 that include the PAFAH1B1 gene can cause Miller-Dieker syndrome.
What is a gene?
Genes are stretches of DNA that give your cells instructions for making molecules or directing activities in the body. Some genes provide the information needed to make proteins, which carry out much of the cell’s work. Others mainly regulate when, where, and how much certain processes take place. Taken together, genes affect how the body develops and works, and they can influence how you respond to food, stress, and medications. For a more detailed look at this subject, you can find more in the LearnHub.
Overview
PAFAH1B1Gene function
What if the gene works
The PAFAH1B1 gene helps guide nerve cells to the right place as the brain develops. It also supports cell movement and the internal transport systems cells use to divide and stay organized.
Risk
What if the gene does not work
When the PAFAH1B1 gene does not work properly, brain development can be disrupted, causing lissencephaly, developmental delay, and seizures. Milder to more severe variants may affect how early signs appear and how pronounced the features are.
Treatment
What does that mean for your treatment
At present, no treatment or management approach specific to the PAFAH1B1 gene is established. Care is supportive, and medicines are chosen for a person’s symptoms, such as seizures or feeding problems, rather than for the PAFAH1B1 variant itself.
Conditions associated with PAFAH1B1
Gene function
What if the gene works
PAFAH1B1 helps cells control movement and internal transport, especially while the brain is developing. Its protein works with the cell’s transport machinery to move structures into place and support orderly cell division. This steady guidance is important for placing developing nerve cells where they belong.
Inside cells, PAFAH1B1 helps guide dynein, a motor protein that carries cargo along tiny tracks called microtubules. This supports the movement of important cell parts to the right place at the right time.
During brain development, PAFAH1B1 helps young nerve cells move to their planned locations. That careful positioning supports the brain’s layered structure and organized wiring.
PAFAH1B1 helps line up the cell’s division machinery so new cells split in a controlled, balanced way. It also helps position the spindle (the structure that pulls chromosomes apart) during this process.
What is a variant?
A genetic variant is a small change in the DNA sequence of a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not cause any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
In the PAFAH1B1 gene, variants can reduce LIS1 protein levels or weaken its work with dynein (a cell transport motor), disrupting nerve cell movement in the developing brain. How PAFAH1B1 gene variants affect brain development depends on how much activity remains. Milder variants may leave some function, while more severe variants, including whole gene deletions, can remove most or all of it. This is linked to a spectrum from milder lissencephaly to earlier, broader features when nearby genes are deleted.
How variants are linked to conditions
Pathogenic variants in the PAFAH1B1 gene cause PAFAH1B1-related lissencephaly, a brain development condition often found in babies or children with low muscle tone, feeding difficulties, developmental delay, or seizures. Larger missing pieces of chromosome 17 that include the PAFAH1B1 gene cause Miller-Dieker syndrome, which usually includes lissencephaly and broader developmental effects. These are established diagnostic associations rather than common risk findings.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widely present in the general population. Most do not directly affect health and instead reflect normal human variation. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definitive diagnosis, especially when several genes and environmental factors play a role. In some situations, though, a single well-established variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For PAFAH1B1, risk is mainly determined by the genetic change itself, not by diet, exercise, or other day-to-day habits. A family history of a PAFAH1B1-related condition, or a parent carrying the change or a chromosome rearrangement involving this gene, can increase the chance in a pregnancy.
Inheritance of PAFAH1B1 variants
For families looking into how PAFAH1B1 gene variants are inherited, the usual pattern is autosomal dominant. This means a person with a disease-causing variant in one copy of the PAFAH1B1 gene can pass it on to each child with a 50% chance. Many people with a PAFAH1B1-related condition have a new (de novo) variant, which means it started in them and was not inherited from either parent. When a parent carries the variant, it can be passed to sons or daughters.
What does my PAFAH1B1 result mean for my family?
A disease-causing change in the PAFAH1B1 gene is usually passed in a dominant way, so close relatives such as parents, brothers, sisters, and children may also carry the same change and may want to discuss testing. In many families, though, the change happens for the first time in the affected child, so a parent is not always the source. The exact family impact can also depend on whether the result is a change in PAFAH1B1 alone or part of a larger missing piece of a chromosome.
Genetic information
Genetic testing
How you find out about variants
In practice, how genetic testing for PAFAH1B1 variants works is straightforward: a lab studies DNA from blood, saliva, or a cheek swab using sequencing and, when needed, tests that look for missing or extra pieces of DNA. Results can show whether a variant or a larger missing segment involving the PAFAH1B1 gene is present.
When should I consider getting a genetic test?
Consider testing for the PAFAH1B1 gene if a child has a very smooth brain on imaging, major developmental delays, low muscle tone, or early seizures, or if there is a family history of this condition. Testing can help confirm the cause and clarify recurrence risk for future pregnancies.
A genetic result is only one part of your health story
A genetic finding can be informative, yet the amount it explains varies depending on the condition and the kind of variant present. Over time, many factors influence how the body functions, including lifestyle, environment, age, and medical history. For some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result can give a clear answer. In areas such as medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the body, or responds to it at its target. This helps explain why the same medication may work well for one person, seem less effective for another, or cause more side effects in someone who is more sensitive to it.
What is Pharmacogenetics?
Pharmacogenetics explores how genetic differences can shape a person’s response to medications. It looks at relationships between genes and drugs to better understand why the same treatment may work differently from one person to another. For many medicines, genes influence both how the body processes a drug and how strong its effects may be. This information can help support more individualized and informed treatment decisions. To explore this topic further, you can learn more in the LearnHub.
Drugs influenced by the PAFAH1B1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in how people respond to medicines, so medication side effects, new symptoms, or questions about treatment are best discussed with your doctor.
History
PAFAH1B1 first came to medical attention through studies of lissencephaly, a rare condition in which the brain surface develops with unusually smooth folds. In the 1990s, researchers linked loss of this gene on chromosome 17 to isolated lissencephaly and to Miller-Dieker syndrome, helping explain why some children shared a similar pattern of brain development differences. Initially understood only through visible traits, later recognized as tied to a specific gene, this discovery marked an important step in modern neurogenetics. Building on this early work, scientists identified PAFAH1B1 as the same gene once commonly called LIS1. That finding helped connect chromosome studies, brain imaging, and genetic testing into a clearer picture of inherited and de novo causes of lissencephaly.